So-Young’s Strategic Shift Leads to Profitable Q2

So-Young International (SY) has released an update.

So-Young International Inc. reported a slight revenue decline to RMB407.4 million in Q2 2024 from RMB412.1 million in the same quarter the previous year, but saw a turnaround to net income of RMB18.9 million compared to a loss in Q2 2023. The company’s strategic initiatives have led to robust sales growth in medical products and maintenance services by 22.6%. Despite the dip in revenue, the company has made significant progress in expanding its clinic chain and product development, indicating a strategic shift that may interest investors observing the medical aesthetics sector.

For further insights into SY stock, check out TipRanks’ Stock Analysis page.